ISSN 1673-3770 CN 37-1437/R
山东大学耳鼻喉眼学报 ›› 2016, Vol. 30 ›› Issue (2): 23-27.doi: 10.6040/j.issn.1673-3770.1.2016.07
陈晓红
CHEN Xiaohong
中图分类号:
| [1] Machens A, Gimm O, Hinze R, et al. Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties[J]. J Clin Endocrinol Metab, 2001, 86(3):1104-1109. [2] Mulligan L M. RET revisited: expanding the oncogenic portfolio[J]. Nat Rev Cancer, 2014, 14(3):173-186. [3] Wells S A Jr, Asa S L, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma[J]. Thyroid, 2015, 25(6):567-610. [4] 王笑春, 易凡, 支凯林. 甲状腺髓样癌不同手术方式对预后影响(附46例报告)[J]. 临床军医杂志, 2006,34(3):305-306. [5] Romanchishen A F, Lisovsky O V, Vabalayte K V. Choice of the optimal volume of surgery for patients with sporadic medullary thyroid cancer[J]. Inter J Head Neck Surgery, 2011, 2(1):11. [6] Machens A, Hauptmann S, Dralle H. Prediction of lateral lymph node metastases in medullary thyroid cancer[J]. Br J Surgery, 2008, 95(5):586-591. [7] Sippel R S, Muthusamy K, Herbert C. Current management of medullary thyroid cancer[J]. Oncologist, 2008, 13(5):539-547. [8] Kloos R T, Eng C, Evans D B, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association[J]. Thyroid, 2009, 19(6):565-612. [9] Philip F, Jacob J J, Nihal T, et al. Medullary thyroid carcinoma: a 20-year experience from a centre in South India[J]. Anz J Surgery, 2007, 77(3):130-134. [10] Kandil E, Gilson M M, Alabbas H H, et al. Survival Implications of Cervical Lymphadenectomy in Patients with Medullary Thyroid Cancer[J]. Ann Surgical Oncol, 2010, 18(4):1028-1034. [11] Schwartz D L, Vishal R, Stephanie S, et al. Postoperative radiotherapy for advanced medullary thyroid cancer-local disease control in the modern era[J]. Head & Neck, 2008, 30(7):883-888. [12] Call J A, Caudill J S, Mciver B, et al. A role for radiotherapy in the management of advanced medullary thyroid carcinoma: the mayo clinic experience[J]. Rare Tumors, 2013, 5:e37. [13] Cosma M P, Panariello L, Quadro L, et al. A mutation in the RET proto-oncogene in Hirschsprungs disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B[J]. Biochem J, 1996, 314(Pt 2):397-400. [14] Rossella E, Schlumberger M J, Müller S P, et al. Cabozantinib in progressive medullary thyroid cancer[J]. J Clin Oncol Official J Am Society Clin Oncol, 2013, 31(29):3639-3646. |
| [1] | 刘晓静,王愿,张立庆,冯剑,赵青,宋圣花,周涵,董伟达. 鼻窦骨纤维异常增殖症36例临床分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 73-78. |
| [2] | 吕丹,李明霞,马兰枝,张馨元,肖浩,陈飞,刘均,李珍. 累及纵膈的头颈部丛状I型神经纤维瘤病两例[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 82-86. |
| [3] | 谢朝峰,林宏浩. 慢性鼻-鼻窦炎手术预后的临床影响因素分析[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 90-93. |
| [4] | 马荣峰,朱富高,孙美红,付涛,张晓恒,曹琳. 突发性聋预后的相关因素分析及疗程选择[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 69-74. |
| [5] | 龚单春,张海东,张庆翔,何双八,于振坤. 精细化甲状腺腺叶切除操作技术[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 5-9. |
| [6] | 房居高. 强化手术技能和规范诊疗是提高甲状腺癌疗效的根本[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 1-4. |
| [7] | 王宇,马奔. 超声引导下热消融技术尚不适用于甲状腺癌及甲状腺滤泡性肿瘤治疗[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 20-22. |
| [8] | 车娟, 赵洪春, 李金玲, 王延飞. D-二聚体与鼻咽癌预后的关系[J]. 山东大学耳鼻喉眼学报, 2015, 29(5): 47-49. |
| [9] | 徐增瑞, 张建新, 石继红, 蔡晓岚. 异种脱细胞真皮基质修复膜修复甲状腺癌切除术后气管缺损13例[J]. 山东大学耳鼻喉眼学报, 2015, 29(5): 52-54. |
| [10] | 刘花, 陈贤明. 鼻腔鼻窦胚胎型横纹肌肉瘤2例并相关文献复习[J]. 山东大学耳鼻喉眼学报, 2014, 28(6): 92-95. |
| [11] | 庄大勇，贺青卿，范子义，郑鲁明，朱见，周鹏，段松建，岳涛，董学峰. 术中神经监测技术在分化型甲状腺癌再次手术中的应用[J]. 山东大学耳鼻喉眼学报, 2013, 27(6): 5-8. |
| [12] | 单良1，陈文文1，倪关森1，罗禹2. 周围性面瘫的MRI增强扫描检查和损伤节段观察及预后相关性分析[J]. 山东大学耳鼻喉眼学报, 2013, 27(6): 28-30. |
| [13] | 梁志成，覃冠锻，莫炼. 特发性突聋伴眩晕对患者预后的影响[J]. 山东大学耳鼻喉眼学报, 2012, 26(2): 42-43. |
| [14] | 刘亦青,李红,纪宏志,何明强,时光刚. 165例慢性鼻-鼻窦炎患者变应性相关临床资料分析[J]. 山东大学耳鼻喉眼学报, 2011, 25(6): 74-. |
| [15] | 李大伟,董频,高尚. 喉鳞癌中P糖蛋白表达与细胞增殖、凋亡及预后的关系[J]. 山东大学耳鼻喉眼学报, 2011, 25(4): 8-12. |
|
||